Thrombolytic therapy in acute myocardial infarction: Some reservations
- 1 November 1993
- journal article
- editorial
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 46 (11) , 1237-1241
- https://doi.org/10.1016/0895-4356(93)90087-h
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarctionJournal of the American College of Cardiology, 1991
- Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trialJournal of the American College of Cardiology, 1991
- Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusionJournal of the American College of Cardiology, 1991
- Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial InfarctionAnnals of Internal Medicine, 1990
- Prehospital thrombolysis in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarctionClinical Cardiology, 1990
- Very early thrombolytic therapy in suspected acute myocardial infarctionThe American Journal of Cardiology, 1990
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986